Indication
Atherosclerotic cardiovascular disease
Atherosclerotic cardiovascular disease is an umbrella clinical term encompassing disorders of the arterial vascular system caused by atherosclerosis, predominantly affecting adult populations. Read more about Atherosclerotic cardiovascular disease
205 drugs 99 manufacturers
Drugs that treat it
Common Atherosclerotic cardiovascular disease therapies.
ATORVASTATIN CALCIUM
ATORVASTATIN CALCIUM
PRAVACHOL (pravastatin sodium)
ATORVASTATIN CALCIUM
FLUVASTATIN SODIUM
ATORVASTATIN CALCIUM
ATORVASTATIN (atorvastatin calcium)
PRAVASTATIN (pravastatin sodium)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonAtherosclerotic cardiovascular disease is an umbrella clinical term encompassing disorders of the arterial vascular system caused by atherosclerosis, predominantly affecting adult populations.
Pathophysiologically, it is initiated by endothelial injury and chronic vascular inflammation, leading to subendothelial lipid accumulation and the formation of fibrofatty plaques within medium and large arteries.
Over time, plaque expansion, luminal stenosis, or acute plaque rupture and thrombosis compromise organ perfusion, clinically manifesting as coronary heart disease, ischemic cerebrovascular disease, peripheral artery disease, or aortic atherosclerotic disease.
- heart.org
Atherosclerotic cardiovascular disease is an umbrella clinical term encompassing disorders of the arterial vascular system caused by atherosclerosis, predominantly affecting adult populations Over time, plaque expansion, luminal stenosis, or acute plaque rupture and thrombosis compromise organ perfusion, clinically manifesting as coronary heart disease, ischemic cerebrovascular disease, peripheral artery disease, or aortic atherosclerotic disease
- nih.gov
Atherosclerotic cardiovascular disease is an umbrella clinical term encompassing disorders of the arterial vascular system caused by atherosclerosis, predominantly affecting adult populations Pathophysiologically, it is initiated by endothelial injury and chronic vascular inflammation, leading to subendothelial lipid accumulation and the formation of fibrofatty plaques within medium and large arteries Over time, plaque expansion, luminal stenosis, or acute plaque rupture and thrombosis compromis...
- nih.gov
Pathophysiologically, it is initiated by endothelial injury and chronic vascular inflammation, leading to subendothelial lipid accumulation and the formation of fibrofatty plaques within medium and large arteries
- nih.gov
Pathophysiologically, it is initiated by endothelial injury and chronic vascular inflammation, leading to subendothelial lipid accumulation and the formation of fibrofatty plaques within medium and large arteries
- mayoclinic.org
Over time, plaque expansion, luminal stenosis, or acute plaque rupture and thrombosis compromise organ perfusion, clinically manifesting as coronary heart disease, ischemic cerebrovascular disease, peripheral artery disease, or aortic atherosclerotic disease
Personalize your experience
Follow Atherosclerotic cardiovascular disease and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.